Anna Rowe graduated with a 2:1 BSc (Hons) in Pharmacology from Sunderland University in 1999 before moving to Birmingham University. Anna graduated with an MSc in Toxicology in 2000, and completed her PhD in 2006. Her PhD investigated the role of Platelet Activating Factor in Necrotising Enterocolitis in premature neonates.
Anna joined CRCTU as a Trial Co-ordinator within the Early Drug Development Team in 2009 and was promoted to the role of Senior Trial Coordinator in 2015 (Early Drug Development/ Diagnostics, Drugs, Devices and Biomarker teams). She was appointed as a Trial Management Team Leader in 2018 for the Inflammation – Advanced and Cellular Therapy team.
Anna’s trial experience is predominantly within early phase trials in both oncology and non-oncology, which includes the use of cell therapy products and novel compounds.
Anna is responsible for a portfolio of trials covering a range of areas including oncology, auto-immune liver conditions, Rheumatoid Arthritis and Inflammatory Bowel Disease.